Tool using BRET for determination of CRISPR/Cas9 restriction efficiency

Kurzbeschreibung:
The technology comprises a new method involving bioluminescence resonance energy transfer (BRET) ratio for determination of restriction efficiency of endonucleases or endonuclease systems comprising a guide-RNA that are used for induction of double-strand breaks at a DNA target sequence of interest for genome editing approaches. The method is suitable for high throughput analyses of potential DNA target sites in combination with different endonucleaseguide-RNA complexes, e.g. CRISPR-Cas9-gRNA complexes.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de

Weiterempfehlen